More importantly, differing from the statin-mediated indiscriminate inhibition of HMGCR in normal and tumor cells, the differential responses of HMGCR to isoprenoid-mediated downregulation render tumor cells more sensitive to isoprenoid-induced growth suppression (Mo et al., 2013). Here, HMGCR is linked to neoplasm.